Qingdao Vland Biotech Co., Ltd.

Qingdao Vland Biotech Co. has faced a notable decline in its stock price, reflecting broader market pressures as the Shanghai Composite index also fell. The company has struggled with weak performance over the past week and month, alongside challenges in financial metrics and consecutive quarterly losses.

Qingdao Vland Biotech Co., Ltd. faced a notable decline in its stock today, reaching an intraday low. The company's recent performance has been challenging, with negative results over the past three quarters and a low operating profit margin. Its market capitalization stands at CNY 3,387 million.

Qingdao Vland Biotech Co., Ltd. has recently experienced a change in its evaluation, influenced by its stock's technical indicators. The company shows mixed financial performance, with net sales growing but facing challenges in profitability. Key metrics indicate low efficiency and a relatively high valuation, alongside a modest dividend yield.